During cancer development, genes that normally function to mediate human development and gametogenesis can become aberrantly activated, driving important features of cancer progression and therapeutic resistance.

These gene include those that encode developmental-specific transcription factors, proteins previously thought to be ‘undruggable’.

Ceridwen Oncology has applied innovative technologies to open up a new space in oncology drug discovery to treat a range of malignancies, including rare cancers that currently have no effective treatment options.